about
Addiction science: Uncovering neurobiological complexityNeuroimmune basis of methamphetamine toxicityLipid tucaresol as an adjuvant for methamphetamine vaccine development.Treatment of methamphetamine abuse: an antibody-based immunotherapy approach.Facial recognition of heroin vaccine opiates: type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphineLiposomes containing monophosphoryl lipid A: a potent adjuvant system for inducing antibodies to heroin hapten analogs.Cocaine analog coupled to disrupted adenovirus: a vaccine strategy to evoke high-titer immunity against addictive drugs.Systems-level view of cocaine addiction: the interconnection of the immune and nervous systems.Synthesis of mercapto-(+)-methamphetamine haptens and their use for obtaining improved epitope density on (+)-methamphetamine conjugate vaccines.A conjugate vaccine attenuates morphine- and heroin-induced behavior in ratsAdjuvants for vaccines to drugs of abuse and addiction.Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriersPharmacokinetic strategies for treatment of drug overdose and addiction.An antidote for acute cocaine toxicity.Synthesis of Hapten-Protein Conjugate Vaccines with Reproducible Hapten Densities.Anti-cocaine vaccine based on coupling a cocaine analog to a disrupted adenovirus.Disrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats.Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food.Probing the effects of hapten stability on cocaine vaccine immunogenicity.Nicotine vaccines to treat tobacco dependence.Long-acting Preparations in Substance Abuse Management: A Review and Update.Virus-based nanoparticles as platform technologies for modern vaccines.Epigenetics: a link between addiction and social environment.Methamphetamine Vaccines: Improvement through Hapten Design.
P2860
Q22251251-A721D6EB-6EFD-459D-A368-727440533ADCQ28247084-295D4B05-F591-4878-9590-EE59E20C960EQ33662748-89655A25-2F4D-48F1-849E-E01D4713DEC5Q33810798-DA60473A-7B3B-46EE-9F2A-2748F6817AD3Q33874955-F06DFA41-6AC1-4B9D-92F7-224DF3C85FB3Q33994987-04BFB913-5202-4188-9ED3-BE31A12DD386Q34157554-ABABBBC5-26B9-4272-979C-A3BC0022E2F5Q34438529-A88D395A-740A-4900-8D08-E9E3AEF35987Q35120379-4668129C-428F-4E8B-9126-50212D53A062Q35224297-681B278A-26F3-45FA-8162-CAEBFF36B918Q35493923-B8F5853B-3E60-4A37-9D91-4705F5DA3B3FQ35756201-55B857D0-854D-4637-8F43-5149E0C0E1F5Q35813574-CC6E8A41-752B-4535-8D69-63D7F19DCDB9Q35869933-167B1FE3-722F-4CFF-9248-973A1A90A89DQ35989208-9F192BD0-37EC-41C0-B270-221FCC54CDFDQ36014803-AFE18358-5D16-459C-B0A0-2A98D79FE3CDQ36562614-F2836BAD-5BDB-4E03-BD1F-776187BA0DF4Q36945794-81F3040B-EAF6-429B-B306-B7D64366F109Q37052393-0BDDB526-104A-43B5-BB6C-ABFB1C3A726BQ37082190-BFC559BD-8068-4FBB-A64C-B10A65E00274Q37219079-85BD78FD-4722-4226-B925-486A099B3FAFQ37329852-44B2DC6D-D658-416F-BF1B-B664C5925AF0Q37624530-79C1E732-328A-47C6-8149-867CD9E951E4Q38056382-67CCA3FC-2ECB-47A1-A2C7-3BF96E1C9F6CQ38119942-59F4B26E-3279-4A5F-8EED-5EEBA1B94837Q38702017-BAD39FF9-14AD-42E8-B385-BD8959E3511BQ39159282-FC6020C3-BD60-45DA-8CF5-C6E97F72A554Q42113438-973691A2-1916-419F-8AE4-6E1A23269EAD
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Anti-drug vaccines to treat substance abuse.
@en
Anti-drug vaccines to treat substance abuse.
@nl
type
label
Anti-drug vaccines to treat substance abuse.
@en
Anti-drug vaccines to treat substance abuse.
@nl
prefLabel
Anti-drug vaccines to treat substance abuse.
@en
Anti-drug vaccines to treat substance abuse.
@nl
P2860
P356
P1476
Anti-drug vaccines to treat substance abuse.
@en
P2093
Berma M Kinsey
Frank M Orson
P2860
P304
P356
10.1038/ICB.2009.17
P577
2009-03-31T00:00:00Z